A similar calculation was performed for patients in the EPO arm to determine whether there was an overall trend in both groups to a decrease in dose over time.
← all excerpts
Costs Associated With Intravenous Darbepoetin Versus Epoetin Therapy in Hemodialysis Patients: A Randomized Controlled Trial.
1
—
—